{"id":"W3166512992","doi":"10.1093/ecco-jcc/jjab075.027","title":"OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn’s Disease: Results from the phase 2 GALAXI 1 study","year":2021,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Calprotectin; Internal medicine; Gastroenterology; Crohn's disease; Clinical trial; Clinical endpoint; Surrogate endpoint; Ustekinumab; Surgery; Disease; Infliximab; Inflammatory bowel disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002007424,0.0006513269,0.001368106,0.0001663965,0.0001620053,0.0004953787,0.0003317919,0.000522728,0.00130079],"category_scores_gemma":[0.001173332,0.0002048223,0.001153993,0.0001564686,0.0004327389,0.0003566249,0.0003402554,0.001067611,0.0002205248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002449632,"about_ca_system_score_gemma":0.0004801457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002542987,"about_ca_topic_score_gemma":0.0005012846,"domain_scores_codex":[0.9993572,0.0004216214,0.00004247004,0.00005937845,0.00005354802,0.00006589082],"domain_scores_gemma":[0.9990981,0.0002469539,0.0002352139,0.00006008636,0.00005112391,0.0003085711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8943712,0.008502993,0.02138481,0.0007076312,0.002056675,0.00008547261,0.0001008001,0.0006473423,0.01437911,0.00006965263,0.0008782668,0.0568162],"study_design_scores_gemma":[0.2965111,0.5454904,0.1501544,0.0001031029,0.002341219,0.0001380975,0.00007926006,0.0008179699,0.002394219,0.0001492419,0.001786021,0.00003486002],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949583,0.003719785,0.0001515269,0.0001492501,0.00003289746,0.0002069901,0.0002572869,0.00001408235,0.0005099432],"genre_scores_gemma":[0.997344,0.0009756541,0.0002963846,0.0002285657,0.0001014761,0.0002405645,0.0004046827,0.00000397712,0.0004047388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002007424,"threshold_uncertainty_score":0.01061642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02397025332142099,"score_gpt":0.3131827910181891,"score_spread":0.2892125376967681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}